Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells
- PMID: 15326102
- DOI: 10.1167/iovs.04-0128
Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells
Abstract
Purpose: Platelet-activating factor (PAF) is a potent proinflammatory mediator that accumulates in the cornea after injury and induces the expression of genes related to inflammation and wound healing. The current study was conducted to investigate the direct effect of PAF on corneal neovascularization and on the expression of angiogenic growth factors in vascular endothelial cells.
Methods: Pellets containing carbamyl-PAF (cPAF) were implanted in corneas of wild-type or PAF-receptor (PAF-R)-knockout mice, and the progression of angiogenesis was monitored by microscope. In some experiments, mice were treated with a daily intraperitoneal injection of the PAF-R antagonist LAU8080. Migration assays of human umbilical cord vein endothelial cells (HUVECs) and human dermal microvascular endothelial cells (HMVECs) were performed in a Boyden chamber after addition of various concentrations of cPAF or bovine fibroblast growth factor (FGF-2). Cell proliferation was assessed by fluorescence-binding assay in the presence of cPAF or FGF-2 for 8 days. Vascular endothelial growth factor (VEGF) and FGF-2 expression was studied by RT-PCR and Northern- and Western-blot analyses in cells stimulated with cPAF at different concentrations and for different times.
Results: Six days after cPAF pellet implantation, there were new vessels growing from the limbus to the center of the cornea. The PAF-induced neovascularization was significantly reduced in PAF-R-knockout mice and in mice treated with the PAF antagonist. cPAF added to the lower well of the Boyden chamber produced a dose-dependent migration of HUVECs and HMVECs that was inhibited in cells preincubated with LAU8080 or with a VEGF-blocking antibody. In contrast, cPAF did not stimulate proliferation of endothelial cells. cPAF induced VEGF mRNA and protein expression but not FGF-2 expression in HUVECs and HMVECs.
Conclusions: PAF stimulates corneal neovascularization by a receptor-mediated mechanism. Induction of VEGF expression and stimulation of vascular endothelial cell migration are initial events in PAF-promoted corneal angiogenesis.
Copyright Association for Research in Vision and Ophthalmology
Similar articles
-
Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing.Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1696-702. Invest Ophthalmol Vis Sci. 2000. PMID: 10845588
-
Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.Invest Ophthalmol Vis Sci. 2005 Feb;46(2):454-60. doi: 10.1167/iovs.04-0753. Invest Ophthalmol Vis Sci. 2005. PMID: 15671269
-
Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium.Invest Ophthalmol Vis Sci. 1995 Feb;36(2):345-54. Invest Ophthalmol Vis Sci. 1995. PMID: 7843905
-
LYP, a bestatin dimethylaminoethyl ester, inhibited cancer angiogenesis both in vitro and in vivo.Microvasc Res. 2011 Sep;82(2):122-30. doi: 10.1016/j.mvr.2011.05.008. Epub 2011 Jun 12. Microvasc Res. 2011. PMID: 21664364 Review.
-
[Role of fibroblast growth factor-2 in tumor angiogenesis].Pathol Biol (Paris). 1999 Apr;47(4):364-7. Pathol Biol (Paris). 1999. PMID: 10372406 Review. French.
Cited by
-
A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis.PLoS One. 2013 Jun 27;8(6):e68173. doi: 10.1371/journal.pone.0068173. Print 2013. PLoS One. 2013. PMID: 23826375 Free PMC article.
-
Novel aspects of corneal angiogenic and lymphangiogenic privilege.Prog Retin Eye Res. 2010 May;29(3):208-48. doi: 10.1016/j.preteyeres.2010.01.002. Epub 2010 Jan 25. Prog Retin Eye Res. 2010. PMID: 20100589 Free PMC article. Review.
-
Corneal neovascularization: an anti-VEGF therapy review.Surv Ophthalmol. 2012 Sep;57(5):415-29. doi: 10.1016/j.survophthal.2012.01.007. Surv Ophthalmol. 2012. PMID: 22898649 Free PMC article. Review.
-
PAF-induced inflammatory and immuno-allergic ophthalmic diseases and their mitigation with PAF receptor antagonists: Cell and nuclear effects.Biofactors. 2022 Nov;48(6):1226-1249. doi: 10.1002/biof.1848. Epub 2022 May 20. Biofactors. 2022. PMID: 35594054 Free PMC article. Review.
-
Significance of lipid mediators in corneal injury and repair.J Lipid Res. 2010 May;51(5):879-91. doi: 10.1194/jlr.R001347. Epub 2009 Nov 3. J Lipid Res. 2010. PMID: 19965607 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases